Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Outcomes of stereotactic radiotherapy for cranial and extracranial metastatic renal cell carcinoma: a systematic review.

Kothari G, Foroudi F, Gill S, Corcoran NM, Siva S.

Acta Oncol. 2015 Feb;54(2):148-57. doi: 10.3109/0284186X.2014.939298. Review.

PMID:
25140860
2.

Factors affecting survival in 37 consecutive patients undergoing de novo stereotactic radiosurgery for contiguous sites of vertebral body metastasis from renal cell carcinoma.

Sellin JN, Reichardt W, Bishop AJ, Suki D, Rhines LD, Settle SH, Brown PD, Li J, Rao G, Chang EL, Tatsui CE.

J Neurosurg Spine. 2015 Jan;22(1):52-9. doi: 10.3171/2014.9.SPINE1482.

PMID:
25360530
3.

Multidose stereotactic radiosurgery (9 Gy × 3) of the postoperative resection cavity for treatment of large brain metastases.

Minniti G, Esposito V, Clarke E, Scaringi C, Lanzetta G, Salvati M, Raco A, Bozzao A, Maurizi Enrici R.

Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):623-9. doi: 10.1016/j.ijrobp.2013.03.037.

PMID:
23683828
4.

A prospective Phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma.

Svedman C, Sandström P, Pisa P, Blomgren H, Lax I, Kälkner KM, Nilsson S, Wersäll P.

Acta Oncol. 2006;45(7):870-5.

PMID:
16982552
5.

Clinical outcome of stereotactic radiosurgery for central nervous system metastases from renal cell carcinoma.

Seastone DJ, Elson P, Garcia JA, Chao ST, Suh JH, Angelov L, Rini BI.

Clin Genitourin Cancer. 2014 Apr;12(2):111-6. doi: 10.1016/j.clgc.2013.10.001.

PMID:
24331575
6.

Management of spinal metastases from renal cell carcinoma using stereotactic body radiotherapy.

Nguyen QN, Shiu AS, Rhines LD, Wang H, Allen PK, Wang XS, Chang EL.

Int J Radiat Oncol Biol Phys. 2010 Mar 15;76(4):1185-92. doi: 10.1016/j.ijrobp.2009.03.062.

PMID:
19632064
7.

Single-fraction stereotactic body radiotherapy for spinal metastases from renal cell carcinoma.

Balagamwala EH, Angelov L, Koyfman SA, Suh JH, Reddy CA, Djemil T, Hunter GK, Xia P, Chao ST.

J Neurosurg Spine. 2012 Dec;17(6):556-64. doi: 10.3171/2012.8.SPINE12303.

PMID:
23020208
8.

A systematic review of stereotactic radiotherapy ablation for primary renal cell carcinoma.

Siva S, Pham D, Gill S, Corcoran NM, Foroudi F.

BJU Int. 2012 Dec;110(11 Pt B):E737-43. doi: 10.1111/j.1464-410X.2012.11550.x. Review.

10.

Analysis of prognostic factors for patients with single brain metastasis treated with stereotactic radiosurgery.

Fernandez-Vicioso E, Suh JH, Kupelian PA, Sohn JW, Barnett GH.

Radiat Oncol Investig. 1997;5(1):31-7.

PMID:
9303054
11.

Spine stereotactic body radiotherapy for renal cell cancer spinal metastases: analysis of outcomes and risk of vertebral compression fracture.

Thibault I, Al-Omair A, Masucci GL, Masson-Côté L, Lochray F, Korol R, Cheng L, Xu W, Yee A, Fehlings MG, Bjarnason GA, Sahgal A.

J Neurosurg Spine. 2014 Nov;21(5):711-8. doi: 10.3171/2014.7.SPINE13895.

PMID:
25170656
12.

Stereotactic radiosurgery without radiation therapy providing high local tumor control of multiple brain metastases from renal cell carcinoma.

Muacevic A, Kreth FW, Mack A, Tonn JC, Wowra B.

Minim Invasive Neurosurg. 2004 Aug;47(4):203-8.

PMID:
15346315
13.

Three-staged stereotactic radiotherapy without whole brain irradiation for large metastatic brain tumors.

Higuchi Y, Serizawa T, Nagano O, Matsuda S, Ono J, Sato M, Iwadate Y, Saeki N.

Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1543-8. doi: 10.1016/j.ijrobp.2008.10.035.

PMID:
19135317
14.

Local control rates of metastatic renal cell carcinoma (RCC) to the bone using stereotactic body radiation therapy: Is RCC truly radioresistant?

Amini A, Altoos B, Bourlon MT, Bedrick E, Bhatia S, Kessler ER, Flaig TW, Fisher CM, Kavanagh BD, Lam ET, Karam SD.

Pract Radiat Oncol. 2015 Nov-Dec;5(6):e589-96. doi: 10.1016/j.prro.2015.05.004.

15.

Radiotherapy for brain metastases from renal cell cancer: should whole-brain radiotherapy be added to stereotactic radiosurgery?: analysis of 88 patients.

Fokas E, Henzel M, Hamm K, Surber G, Kleinert G, Engenhart-Cabillic R.

Strahlenther Onkol. 2010 Apr;186(4):210-7. doi: 10.1007/s00066-010-2055-z.

PMID:
20165820
16.

Stereotactic body radiotherapy for the treatment of oligometastatic renal cell carcinoma.

Ranck MC, Golden DW, Corbin KS, Hasselle MD, Liauw SL, Stadler WM, Hahn OM, Weichselbaum RR, Salama JK.

Am J Clin Oncol. 2013 Dec;36(6):589-95. doi: 10.1097/COC.0b013e31825d52b2.

PMID:
22868242
17.

Gamma-knife radiosurgery for brain metastasis of renal cell carcinoma: results in 42 patients.

Hoshi S, Jokura H, Nakamura H, Shintaku I, Ohyama C, Satoh M, Saito S, Fukuzaki A, Orikasa S, Yoshimoto T.

Int J Urol. 2002 Nov;9(11):618-25; discussion 626; author reply 627.

18.

Radiosurgery for the treatment of brain metastases in renal cell carcinoma.

Becker G, Duffner F, Kortmann R, Weinmann M, Grote EH, Bamberg M.

Anticancer Res. 1999 Mar-Apr;19(2C):1611-7. Review.

PMID:
10365156
19.

Fractionated stereotactic radiotherapy of brain metastases from renal cell carcinoma.

Ikushima H, Tokuuye K, Sumi M, Kagami Y, Murayama S, Ikeda H, Tanaka M, Oyama H, Shibui S, Nomura K.

Int J Radiat Oncol Biol Phys. 2000 Dec 1;48(5):1389-93.

PMID:
11121638
20.

Single-fraction versus multifraction spinal stereotactic radiosurgery for spinal metastases from renal cell carcinoma: secondary analysis of Phase I/II trials.

Ghia AJ, Chang EL, Bishop AJ, Pan HY, Boehling NS, Amini B, Allen PK, Li J, Rhines LD, Tannir NM, Tatsui CE, Brown PD, Yang JN.

J Neurosurg Spine. 2016 May;24(5):829-36. doi: 10.3171/2015.8.SPINE15844.

PMID:
26799117
Items per page

Supplemental Content

Support Center